×
戻る Agenda
Session 4
Session Chair(s)
Taiji Yamasaki
Executive Director, , Study Operations Oncology, MSD K.K., Japan
Kumiko Okada
Study Manager, Clinical Operations, Pfizer R&D, Japan
Speaker(s)
Keisuke Shimizu
, Lung Cancer HER2 “HER HER”, Japan
Yosuke Chiyomori
Clinical Development Manager, Trial Mgmt,Clinical Development Ops & Innovations, Eli Lilly Japan K.K., Japan
Hiroya Komoda
Clinical Project Manager, Clinical Project Management Group, Pfizer R&D Japan, Japan